| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/22/2008 | US7361473 Evaluation of acute coronary syndromes patient test samples are analyzed for the presence and amount of test samples are analyzed for the presence and amount of members of a panel of markers comprising one or more specific markers for |
| 04/22/2008 | US7361471 Nucleic acid archiving |
| 04/22/2008 | US7361466 Nucleic acid analysis using terminal-phosphate-labeled nucleotides |
| 04/22/2008 | US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
| 04/22/2008 | US7361462 Identifying disruption in nucleotide sequence fragment using DNA repair protein and immunoglobulin binding; immunoassay |
| 04/22/2008 | US7361461 enables assessment of dynamic variations in a mixed population of organisms using affinity aided solution hybridization combined with resolution providing fractionation; very sensitive; allow quantitative detection of polynucleotide sequences present in diminutive amounts |
| 04/22/2008 | US7361458 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
| 04/22/2008 | US7361359 Neospora caninum isolate |
| 04/22/2008 | US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection |
| 04/22/2008 | US7361355 Mutant forms of cholera holotoxin as an adjuvant |
| 04/22/2008 | US7361354 Methods for treating malignancies expressing ICAM-1 using coxsackie a group viruses |
| 04/22/2008 | US7361353 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 04/22/2008 | US7361350 Use of an IL-1 antagonist for treating arthritis |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | US7361338 Methods to inhibit growth of prostate cancer cells |
| 04/22/2008 | US7361337 Antibodies against the PRO1754 polypeptides |
| 04/22/2008 | US7361331 Plant bioreactors |
| 04/22/2008 | US7361133 Methods of detection utilizing modified bacteriophage |
| 04/22/2008 | CA2394746C Chromatography material and a method using same |
| 04/22/2008 | CA2390685C Methods and compositions for inhibiting neoplastic cell growth |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |
| 04/22/2008 | CA2353417C Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 04/22/2008 | CA2281001C Microbial production of 1,2-propanediol from sugar |
| 04/22/2008 | CA2211367C Improved method for reverse transcription |
| 04/22/2008 | CA2166063C Production of trehalose in plants |
| 04/22/2008 | CA2112395C Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/17/2008 | WO2008045601A2 Adenovirus-based genetic vaccines for biodefense |
| 04/17/2008 | WO2008045576A2 Compositions and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases |
| 04/17/2008 | WO2008045575A2 Sequencing method |
| 04/17/2008 | WO2008045489A2 Glucoamylase variants with altered properties |
| 04/17/2008 | WO2008045460A2 Maize microrna sequences |
| 04/17/2008 | WO2008045437A2 Chimeric t-cell receptors and t-cells targeting egfrviii on tumors |
| 04/17/2008 | WO2008045380A2 Nucleic acid libraries and their design and assembly |
| 04/17/2008 | WO2008045214A2 Cellulase-free enzyme compositions and host cells for producing the same |
| 04/17/2008 | WO2008044957A1 Proteom differential analysis method |
| 04/17/2008 | WO2008044869A1 Expression vectors with improved safety |
| 04/17/2008 | WO2008044800A1 Mutant plant and method for production thereof |
| 04/17/2008 | WO2008044794A1 Auxiliary reagent for gene transfer |
| 04/17/2008 | WO2008044754A1 Prophylactic or therapeutic agent for cancer |
| 04/17/2008 | WO2008044692A1 Protein suitable for protein orientation control/immobilization and immobilization support for the protein |
| 04/17/2008 | WO2008044660A1 Screening method for prokinetic agent |
| 04/17/2008 | WO2008044631A1 Therapeutic and/or ameliorating agent for disseminated intravascular coagulation |
| 04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
| 04/17/2008 | WO2008044567A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 04/17/2008 | WO2008044504A1 Method for determining tongue cancer |
| 04/17/2008 | WO2008044453A1 Method for production of l-amino acid |
| 04/17/2008 | WO2008044409A1 Method for production of l-amino acid |
| 04/17/2008 | WO2008044379A1 Bone loss model animal |
| 04/17/2008 | WO2008044378A1 Reagent containing fused protein of soluble rankl with epitope tag |
| 04/17/2008 | WO2008044358A1 Primer set for detection of saccharomyces yeast |
| 04/17/2008 | WO2008044351A1 Novel transporter protein in mammal, and use thereof |
| 04/17/2008 | WO2008044150A2 Improvement of the kernel productivity of plants through the modulation of glutamine synthetase activity |
| 04/17/2008 | WO2008044068A2 Combination therapy |
| 04/17/2008 | WO2008043849A2 Plants with increased yield |
| 04/17/2008 | WO2008043847A1 Processing enzymes fused to basic protein tags |
| 04/17/2008 | WO2008043844A1 Preparation of transgenic plants |
| 04/17/2008 | WO2008043826A1 Method for increasing pathogen resistance in transgenic plants |
| 04/17/2008 | WO2008043821A1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof |
| 04/17/2008 | WO2008043777A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | WO2008043753A2 Rna antagonist compounds for the modulation of pcsk9 |
| 04/17/2008 | WO2008043561A2 Influenza targets |
| 04/17/2008 | WO2008043551A1 Methods and kit for isolating nucleic acids |
| 04/17/2008 | WO2008043268A1 Gmrd22-like genes and use thereof to protect against abiotic stress |
| 04/17/2008 | WO2008043245A1 Abiotic stress tolerance conferred by j-domain-containing proteins |
| 04/17/2008 | WO2008043241A1 A fusion protein carrying neurotrophin across the blood-brain barrier, encoding gene and uese thereof |
| 04/17/2008 | WO2008043185A1 Reliable detection of vancomycin-intermediate staphylococcus aureus |
| 04/17/2008 | WO2008043180A1 Immunostimulatory composition comprising recombinant bcg mycobacterium expressing mammalian cysteine protease |
| 04/17/2008 | WO2008043147A1 Process for generation of protein and uses thereof |
| 04/17/2008 | WO2008043145A1 Hybridomas producing antibodies against non functional p2x7 receptor |
| 04/17/2008 | WO2008028119A3 Methods for rapidly transforming monocots |
| 04/17/2008 | WO2008025558A3 Affinity marker comprising a first and a second tag and its use |
| 04/17/2008 | WO2008025516A3 Tnf superfamily fusion proteins |
| 04/17/2008 | WO2008025507A3 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 04/17/2008 | WO2008022046A3 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 04/17/2008 | WO2008019861A3 Method for dissolving charged nucleic acid in an organic liquid |
| 04/17/2008 | WO2008017636A3 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 04/17/2008 | WO2008015480A3 Composition and method for modulating an immune response |
| 04/17/2008 | WO2008013590A3 Implementation of a mitochondrial mutator |
| 04/17/2008 | WO2008012832A3 Direct regeneration of plantlets in jatropha curcas |
| 04/17/2008 | WO2008005474A3 High level antioxidant-containing foods |
| 04/17/2008 | WO2008003783A3 Resistance to powdery mildew and absence of necrosis in cucumis sativus |
| 04/17/2008 | WO2008003103A3 Novel multivalent immunoglobulins |
| 04/17/2008 | WO2007146767A3 Bacterial glutamine synthetases and methods of use |
| 04/17/2008 | WO2007144770A3 Bacterium |
| 04/17/2008 | WO2007144190A3 Plants with modulated expression of nac transcription factors having enhanced yield-related traits and a method for making the same |
| 04/17/2008 | WO2007137973A3 Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (fpp) |
| 04/17/2008 | WO2007134907A3 Gm-csf gene therapy for treatment of crohn's disease using an improved regulated expression system |
| 04/17/2008 | WO2007130154A8 Recombinant production of heparin binding proteins |
| 04/17/2008 | WO2007121054A3 Nucleic acids for apoptosis of cancer cells |
| 04/17/2008 | WO2007117258A9 Growth of wild-type hepatitis a virus in cell culture |
| 04/17/2008 | WO2007104570A3 Nematode control |
| 04/17/2008 | WO2007103988A3 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
| 04/17/2008 | WO2007099230A3 Expression system for yeast for the production of aromatic molecules |
| 04/17/2008 | WO2007095108A3 Isolated luciferase gene of l. italica |
| 04/17/2008 | WO2007095007A3 Systematic genomic library and uses thereof |
| 04/17/2008 | WO2007084773A3 Enhanced production of infectious parvovirus vectors in insect cells |
| 04/17/2008 | WO2007081487A3 Production of human defensins in plant cells |
| 04/17/2008 | WO2007076548A3 RNAi-MEDIATED INHIBITION OF IGFlR FOR TREATMENT OF OCULAR ANGIOGENESIS |
| 04/17/2008 | WO2007076367A3 Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension / glaucoma |